Shares of Altimmune ALT fell 27.04% during market hours on Sep 14, even after the company announced positive top-line results from its 12-week phase I study. The study evaluated pemvidutide in ...
Agios Pharmaceuticals, Inc. stock plunged 49% after mixed Phase 3 results for mitapivat in Sickle Cell Disease, raising doubts about future approvals. Mitapivat met the primary hemoglobin endpoint but ...
According to a new study by Leadership IQ, 46% of newly-hired employees will fail within 18 months, while only 19% will achieve unequivocal success. But contrary to popular belief, technical skills ...
Biohaven Pharmaceuticals BHVN recently announced that the phase II/III HEALY ALS platform study evaluating verdiperstat for treating Amyotrophic Lateral Sclerosis (ALS) failed. ALS is a progressive, ...
To examine the efficacy of EPA’s label in conveying toxicity information to potential consumers, the researchers conduct an incentivized field experiment with eye tracking to evaluate the ...
Learn why so many people fail the CPA exam, what pass rates really reveal, and which study mistakes can hurt candidates ...
Apple customers are generally a shockingly loyal bunch. The company's high repeat customer rate can be attributed to a combination of factors that concern iPhones themselves as well as Apple's ...
According to a new study by Leadership IQ, a global leadership training and research company, 46% of newly hired employees will fail within 18 months. The reason: poor interpersonal skills. The study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results